179 related articles for article (PubMed ID: 30122941)
21. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.
Laban S; Atanackovic D; Luetkens T; Knecht R; Busch CJ; Freytag M; Spagnoli G; Ritter G; Hoffmann TK; Knuth A; Sauter G; Wilczak W; Blessmann M; Borgmann K; Muenscher A; Clauditz TS
Int J Cancer; 2014 Sep; 135(5):1142-52. PubMed ID: 24482145
[TBL] [Abstract][Full Text] [Related]
22. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.
Veit JA; Heine D; Thierauf J; Lennerz J; Shetty S; Schuler PJ; Whiteside T; Beutner D; Meyer M; Grünewald I; Ritter G; Gnjatic S; Sikora AG; Hoffmann TK; Laban S
Head Neck; 2016 Jul; 38(7):1008-16. PubMed ID: 26874246
[TBL] [Abstract][Full Text] [Related]
23. Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.
Iura K; Kohashi K; Hotokebuchi Y; Ishii T; Maekawa A; Yamada Y; Yamamoto H; Iwamoto Y; Oda Y
J Pathol Clin Res; 2015 Jul; 1(3):144-59. PubMed ID: 27499900
[TBL] [Abstract][Full Text] [Related]
24. AKAP4, SPAG9 and NY-ESO-1 in Iranian Colorectal Cancer Patients as Probable Diagnostic and Prognostic Biomarkers.
Tavakoli Koudehi A; Mahjoubi B; Mirzaei R; Shabani S; Mahjoubi F
Asian Pac J Cancer Prev; 2018 Feb; 19(2):463-469. PubMed ID: 29480665
[TBL] [Abstract][Full Text] [Related]
25. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
26. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
27. Possible predictive role of cancer/testis antigens in breast ductal carcinoma
Roguljic A; Spagnoli G; Juretic A; Sarcevic B; Banovic M; Beketic Oreskovic L
Oncol Lett; 2018 Dec; 16(6):7245-7255. PubMed ID: 30546463
[TBL] [Abstract][Full Text] [Related]
28. Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer.
Yang P; Qiao Y; Meng M; Zhou Q
Front Oncol; 2022; 12():864159. PubMed ID: 35574342
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.
Andrade VC; Vettore AL; Felix RS; Almeida MS; Carvalho F; Oliveira JS; Chauffaille ML; Andriolo A; Caballero OL; Zago MA; Colleoni GW
Cancer Immun; 2008 Feb; 8():2. PubMed ID: 18237105
[TBL] [Abstract][Full Text] [Related]
30. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
Pak MG; Shin DH; Lee CH; Lee MK
World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.
Hsu R; Baca Y; Xiu J; Wang R; Bodor JN; Kim C; Khan H; Mamdani H; Nagasaka M; Puri S; Liu SV; Korn WM; Nieva JJ
Oncotarget; 2021 Dec; 12(25):2449-2458. PubMed ID: 34917263
[TBL] [Abstract][Full Text] [Related]
32. Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
Karia BTR; Zamuner FT; Carlin V; de Oliveira CZ; Carvalho AL; Vettore AL
Curr Mol Med; 2017; 17(10):707-717. PubMed ID: 29577858
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
34. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
35. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of the phosphatidylinositol 3-kinase/protein kinase B signal transduction pathway in non-small cell lung carcinoma.
Jiang AG; Yu H; Huang JA
Oncol Lett; 2014 Aug; 8(2):601-607. PubMed ID: 25013474
[TBL] [Abstract][Full Text] [Related]
38. Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients.
Inaoka RJ; Jungbluth AA; Gnjatic S; Ritter E; Hanson NC; Frosina D; Tassello J; Etto LY; Bortoluzzo AB; Alves AC; Colleoni GW
Cancer Immunol Immunother; 2012 Dec; 61(12):2207-14. PubMed ID: 22638551
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.
Lattanzi M; Han J; Moran U; Utter K; Tchack J; Sabado RL; Berman R; Shapiro R; Huang HH; Osman I; Bhardwaj N; Pavlick AC
J Immunother Cancer; 2018 May; 6(1):38. PubMed ID: 29773080
[TBL] [Abstract][Full Text] [Related]
40. Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen.
Bai R; Yuan C
Aging Dis; 2022 Jul; 13(4):1267-1277. PubMed ID: 35855340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
